1. Home
  2. WLFC vs MLTX Comparison

WLFC vs MLTX Comparison

Compare WLFC & MLTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Willis Lease Finance Corporation

WLFC

Willis Lease Finance Corporation

HOLD

Current Price

$120.20

Market Cap

1.0B

ML Signal

HOLD

Logo MoonLake Immunotherapeutics

MLTX

MoonLake Immunotherapeutics

HOLD

Current Price

$13.92

Market Cap

904.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WLFC
MLTX
Founded
1985
2021
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
904.7M
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
WLFC
MLTX
Price
$120.20
$13.92
Analyst Decision
Buy
Analyst Count
0
9
Target Price
N/A
$36.33
AVG Volume (30 Days)
57.4K
2.2M
Earning Date
11-04-2025
11-05-2025
Dividend Yield
1.30%
N/A
EPS Growth
17.99
N/A
EPS
16.70
N/A
Revenue
$674,381,000.00
N/A
Revenue This Year
$16.17
N/A
Revenue Next Year
$4.88
N/A
P/E Ratio
$7.35
N/A
Revenue Growth
29.58
N/A
52 Week Low
$114.01
$5.95
52 Week High
$229.67
$62.75

Technical Indicators

Market Signals
Indicator
WLFC
MLTX
Relative Strength Index (RSI) 45.62 51.96
Support Level $114.01 $12.43
Resistance Level $135.00 $13.99
Average True Range (ATR) 5.23 0.73
MACD 0.20 0.75
Stochastic Oscillator 37.38 95.68

Price Performance

Historical Comparison
WLFC
MLTX

About WLFC Willis Lease Finance Corporation

Willis Lease Finance Corp, with its subsidiaries, is a lessor and servicer of commercial aircraft and aircraft engines. The company has two reportable business segments, which include Leasing and Related Operations and Spare Parts Sales. A majority of its revenue is generated from the Leasing and Related Operations segment, which involves acquiring and leasing, under operating leases, commercial aircraft, aircraft engines, and other aircraft equipment and the selective purchase and resale of commercial aircraft engines, aircraft equipment, and other related businesses. Geographically, the company derives maximum revenue from the United States, followed by Europe, Asia-Pacific (excluding India), India, South America, Canada, Central America, and the Middle East.

About MLTX MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.

Share on Social Networks: